BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2646640)

  • 1. Tumorigenic methylcholanthrene transformants of C3H/10T1/2 cells have a common nucleotide alteration in the c-Ki-ras gene.
    Chen AC; Herschman HR
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1608-11. PubMed ID: 2646640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reassessment of methylcholanthrene transformation in the C3H10T1/2 cell culture system.
    Chen AC; Brankow DW; Herschman HR
    Carcinogenesis; 1990 May; 11(5):817-22. PubMed ID: 2185902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A continuum of transformed phenotypes in C3H/10T1/2 derivatives.
    Chen AC; Herschman HR
    Carcinogenesis; 1988 Sep; 9(9):1695-700. PubMed ID: 3409475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of c-K-ras, c-N-ras and transforming growth factor beta co-segregate with tumorigenicity in morphologically transformed C3H 10T1/2 cell lines.
    Coleman WB; Throneburg DB; Grisham JW; Smith GJ
    Carcinogenesis; 1994 May; 15(5):1005-12. PubMed ID: 8200061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras gene mutation and amplification in human nonmelanoma skin cancers.
    Pierceall WE; Goldberg LH; Tainsky MA; Mukhopadhyay T; Ananthaswamy HN
    Mol Carcinog; 1991; 4(3):196-202. PubMed ID: 2064725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating mutations in human c-Ha-ras-1 gene induced by reactive derivatives of safrole and the glutamic pyrolysis product, Glu-P-3.
    Ireland CM; Cooper CS; Marshall CJ; Hebert E; Phillips DH
    Mutagenesis; 1988 Sep; 3(5):429-35. PubMed ID: 3070278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
    Wang Y; Wang Y; Stoner G; You M
    Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression.
    Brown K; Buchmann A; Balmain A
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):538-42. PubMed ID: 2105486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.
    Watanabe H; Shimokado K; Asahara T; Dohi K; Niwa O
    Jpn J Cancer Res; 1999 Jan; 90(1):40-7. PubMed ID: 10076563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-ras mutation in ultraviolet radiation-induced murine skin cancers.
    Pierceall WE; Kripke ML; Ananthaswamy HN
    Cancer Res; 1992 Jul; 52(14):3946-51. PubMed ID: 1617670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the Ect2 proto-oncogene and over-expression of Ect2 mRNA and protein in nickel compound and methylcholanthrene-transformed 10T1/2 mouse fibroblast cell lines.
    Clemens F; Verma R; Ramnath J; Landolph JR
    Toxicol Appl Pharmacol; 2005 Aug; 206(2):138-49. PubMed ID: 15967202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of activated c-H-ras oncogene in the induction and progression of immortal liver epithelial cell lines derived from normal C3H mice.
    Lee GH; Sakai R; Nagao M; Kitagawa T
    Int J Cancer; 1991 Jan; 47(1):60-5. PubMed ID: 1985880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of a mutant c-Ha-ras oncogene into C3H/10T1/2 cells and its relationship to tumorigenic transformation.
    Manoharan TH; Burgess JA; Ho D; Newell CL; Fahl WE
    Carcinogenesis; 1985 Sep; 6(9):1295-301. PubMed ID: 4028328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of thyroid hormone dose-dependent regulation of K-ras protooncogene expression with oncogene activation by 3-methylcholanthrene: loss of thyroidal regulation in the transformed mouse cell.
    Guernsey DL; Leuthauser SW
    Cancer Res; 1987 Jun; 47(12):3052-6. PubMed ID: 3581059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
    Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
    Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cellular determination on oncogenic transformation by chemicals and oncogenes.
    Harrington MA; Gonzales F; Jones PA
    Mol Cell Biol; 1988 Oct; 8(10):4322-7. PubMed ID: 2460742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of ras oncogenes and expression of tumor-specific transplantation antigens in methylcholanthrene-induced murine fibrosarcomas.
    Carbone G; Borrello MG; Molla A; Rizzetti MG; Pierotti MA; Della Porta G; Parmiani G
    Int J Cancer; 1991 Feb; 47(4):619-25. PubMed ID: 1995490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.